Search Results
Site Search
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
Collagen VII Autoantibody-mediated Subepidermal Autoimmune Blistering Diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., professor of dermatology and laboratory medicine and pathology, discusses a subepidermal disease mediated by collagen VII autoantibodies.
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. - Insights
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.
See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.
New tests launched in August - Insights
In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in February - Insights
In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MCL GynCytology Patient Information MC1235129
MCL GynCytology Patient Information Complete print Reset Form Gyn Cytology Patient Information Instructions Send completed copy form specimen
A Test in Focus Archives - Page 10 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and pathology research roundup: May 30 - Insights
This week's research roundup feature: Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms.
Mayo Clinic Laboratory and pathology research roundup: February 7 - Insights
This week's Research Roundup features: Maintenance of remission and risk of relapse in Myeloperoxidase-positive ANCA-associated Vasculitis with kidney involvement.
Mayo Clinic Laboratory and pathology research roundup: December 28 - Insights
This week’s research roundup features: Risk of late-onset breast cancer in genetically predisposed women.
Mayo Clinic Laboratory and pathology research roundup: May 9 - Insights
This week's research roundup feature: Proprotein Convertase Subtilisin/Kexin Type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Find out more about our cost-effective immunoassay panel, which uses oral fluid testing to support addiction treatment and pain management.
Pathways Case Studies: May 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Bone and Soft Tissue & Infectious...
Cardiovascular Biomarkers of Atherosclerotic Risk - Insights
In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.
mast_cell_disorder_diagnostic_algorithm__bone_marrow.pdf
01/2025© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Mast Cell Disorder: Diagnostic Algorithm, Bone Marrow NORMAL ABNORMAL Mast cells observed Other hematologic cells observed Order initial testing: ■...
CPT codes and LOINC update: December 2024 - Insights
This will be the last CPT Codes and LOINC update. Read why.
Vaping-Associated Lung Injury May Be Caused by Toxic Chemical Fumes, Study Finds - Insights
A Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
Medication-targeted testing - Insights
Learn more about how medication targeted testing at Mayo Clinic Laboratories can assist in treatment optimization for medication with established pharmacogenomic associations.
Pathways Case Studies: August 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for August include the following sub-specialties: Bone and Soft Tissue Pathology,...
The Expanding Reach of the Laboratory Outreach Program - Insights
The most successful laboratory outreach programs recognize the importance of serving multiple customers. From provider to patient to healthcare consumer, the laboratory has an opportunity to serve them all with high-quality results and...
https://www.mayocliniclabs.com/test-catalog/pdf-reports.php
MCL PDF Reports Values current as of July 19, 2025 Mayo Test ID Published Name PDF 2OHGP 2-Hydroxyglutaric Aciduria Gene Panel, Varies Supplemental 3MGAP 3-Methylglutaconic Aciduria Panel, Varies Supplemental ADPKP Focused Autosomal...
Lysosomal metabolism and storage disorders - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can clarify diagnosis of a lysosomal metabolism and storage disorder.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
Hepatocellular Carcinoma Risk Panel with GALAD Score - Insights
In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score...
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal.
https://news.mayocliniclabs.com/file-mfa-user-guide/
Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 10/10/2023 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...
galactosemia_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 07/2024 GALT <24.5 nmol/h/mg of hemoglobin GALT ≥24.5 nmol/h/mg of hemoglobin 2 variants identified 0–1 variants identified and discordant enzyme results 1...
Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 6/27/2024 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...
New tests launched in September - Insights
In September 2021, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratory and Pathology Research Roundup: April 24 - Insights
This week’s Research Roundup highlights the best tumor size cut-points for renal cell carcinoma staging.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 6 - Insights
This week’s Research Roundup highlights how a novel enhancer regulates MGMT expression and promotes temozolomide-resistance in glioblastomas.
Mayo Clinic Laboratory and pathology research roundup: March 15 - Insights
This Feature Includes: Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data.
Infectious Diseases - Insights
Learn how our clinical microbiology laboratory can aid in diagnosing pediatric illnesses caused by insects, fungal species, and parasites.
Pathways Case Studies: March 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cytopathology,...
For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose. To provide meaningful answers, our...
Mayo Clinic Laboratory and pathology research roundup: April 26 - Insights
Top highlights include: Arrhythmia variant associations and reclassifications in the eMERGE-III sequencing study.
Mayo Clinic Laboratory and pathology research roundup: May 10 - Insights
Top highlights include: Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
Inflammatory Bowel Disease - Mayo Clinic Laboratories
Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...
Autoimmune evolution - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...
07/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Abacavir Hypersensitivity Testing and Initial Patient Management Algorithm 1. Saag M, Balu R, Phillips E, et al. High sensitivity of human...
New Tests - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Opioids remain a mainstay of pain management, upping the stakes for monitoring prescription compliance and detecting abuse. Paul Jannetto, Ph.D., Director of the Clinical and Forensic Toxicology Laboratory at Mayo Clinic, and Loralie...